ゴールデンレトリバーの致死性心疾患に関わる遺伝子を特定(Researchers Identify Gene Associated With Deadly Heart Disease in Golden Retrievers)

ad

2025-09-03 ノースカロライナ州立大学(NC State)

Web要約 の発言:
ノースカロライナ州立大学の研究チームは、ゴールデンレトリバーに致死性心疾患「肥大型心筋症(HCM)」を引き起こす初の遺伝的変異を特定した。HCMは左心室の肥厚により血液循環を阻害し、血栓、不整脈、心不全を招くが、犬での遺伝要因の特定は極めて稀だった。研究では2歳未満で突然死した3頭の全ゲノムを解析し、2,500頭以上の犬や野生種と比較。心筋収縮に関わるTNNI3遺伝子にc.593C>Tのミスセンス変異を確認した。この変異は常染色体劣性で、両親が保因者でも発症せず、子犬にのみ症状が現れる。本成果は犬種内での診断や繁殖管理に役立つとともに、人間のHCM研究モデルとしても有望である。研究結果は『Circulation: Genomic and Precision Medicine』に掲載された。

<関連情報>

ゴールデンレトリバーにおける家族性肥大型心筋症に関連する新規心筋トロポニンIミスセンス変異体(c.593C>T) Novel Cardiac Troponin-I Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden Retrievers

Victor N. Rivas, MS, PhD, Dayna A. Goldsmith, DVM, Michael W. Vandewege, PhD, Ronald H.L. Li, MVetMed; DVM, PhD, Sandra M. Losa, MBA, PhD, Meghan Leber, BS, Panchan Sitthicharoenchai, MS, DVM, PhD, Kim Hawkes, DVM, Jennifer L. Davies, MVSc, DVM, Carolyn Legge, MVSc, DVM, Sarah Revell, DVM, and Joshua A. Stern, DVM, PhD
Circulation: Genomic and Precision Medicine  Published: 22 August 2025
DOI:https://doi.org/10.1161/CIRCGEN.125.005096

ゴールデンレトリバーの致死性心疾患に関わる遺伝子を特定(Researchers Identify Gene Associated With Deadly Heart Disease in Golden Retrievers)

Abstract

BACKGROUND:

Hypertrophic cardiomyopathy (HCM) is a naturally occurring cardiac disorder afflicting humans, cats, rhesus macaques, pigs, and rarely dogs. The disease is characterized by maladaptive left ventricular wall thickening. Over 1500 sarcomere-coding mutations explain HCM in humans, whereas only 3 have been reported in cat breeds. To date, no mutations have been described in dogs. HCM in a nuclear family of Golden Retrievers was identified following the sudden cardiac death of 3 related puppies <2 years of age from 2 dam-offspring repeat matings.

METHODS:

Whole-genome sequencing on the 3 affected puppies, along with nuclear family members (ie, sire, dam, 4 unaffected littermates, 4 unaffected half-siblings), and 1 distantly related, geriatric, cardiovascularly normal Golden Retriever was performed (n=14). Candidate variant genotyping was performed in an unphenotyped cohort of dogs (n=2771) and an expanded population of phenotyped, unrelated Golden Retrievers (n=45). Left ventricular tissue immunofluorescence staining was subsequently performed to investigate incorporation and expression of mutant protein within the cardiac sarcomere of HCM-affected cases.

RESULTS:

Gross and histopathologic evaluations of the HCM-affected puppies revealed hallmark features of the disease, including cardiomyocyte hypertrophy, interstitial fibrosis, and left-sided congestive heart failure. Segregation analysis of called variants, performed under assumptions of an autosomal-recessive mode of inheritance, identified a single segregating c.593C>T missense variant in TNNI3 (Cardiac Troponin-I). This variant was not observed in the unphenotyped (n=2771) nor in the phenotyped, unrelated cohort of dogs (n=45). Immunofluorescence staining of left ventricular tissues did not reveal obvious aberrant protein localization and expression at the sarcomeric level, suggesting the molecular pathogenesis of the TNNI3 variant is not related to abnormal protein incorporation within the sarcomere.

CONCLUSIONS:

This variant represents the first-ever reported HCM-associated variant in any canine species, and its identification holds promise for establishing translational models, genetic screening, and early disease prevention within the breed.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました